p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary.
A
A
Kalebi
M
M
Hale
D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000556:secondary; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D010051:Ovarian Neoplasms / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000556:secondary; D015534:Trans-Activators / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000378:metabolism
C115051:TP63 protein, human; D015534:Trans-Activators; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins